What’s the difference between Phase 1 and Phase 2 of Operation Warp Speed?
Phase 1 was a pharmacy-led clinic and Phase 2 will entail facility-led vaccine administration overseen by PharmScript staff.
Phase 1 was a pharmacy-led clinic and Phase 2 will entail facility-led vaccine administration overseen by PharmScript staff.
On the assigned vaccine clinic day, PharmScript will provide the appropriate number of doses for administration according to the number of total consent forms received. Please note that consent forms must be entered 48 hours prior to vaccine day. Vaccine preparation is complicated, and this process minimizes unnecessary vaccine waste. If there are extra doses [...]
State and federal reporting requirements for vaccine administration of the COVID-19 vaccine are handled by PharmScript and reported within 24 hours. It will be imperative that your facility provide completed administration forms for all doses given by end of the business day to assigned CSR in order to submit documentation to State and Federal entities.
Any forms or registration specific to this program will be communicated directly from the pharmacy to your building to ensure compliance.
Due to limited availability, facilities may not be able to receive their desired quantities. With this, we recommend setting priorities on how to distribute the vaccines received at each facility. Our recommendation is noted below: Residents Facility staff with direct patient care responsibilities Facility staff without direct patient care responsibilities and volunteers
PharmScript has set up a COVID section in the PS portal which will contain all relevant COIVD-19 documentation. Prior to each clinic date, around three days before, your facility will receive a call from a PharmScript vaccine team member who will answer any questions you may have. We also encourage you to reach out to [...]
The COVID-19 vaccine contains a small snippet of RNA which encodes the instructions for producing the coronavirus “spike” protein, a protein that helps the virus invade healthy cells. The vaccine recipient’s own cells will make some of this specific protein to elicit the body to produce an immune response. Currently available COVID-19 assays test for [...]
No, the COVID-19 vaccine does not contain cells from aborted fetuses. MRNA vaccines (Pfizer and Moderna) are synthetic vaccines, sequenced on a computer in a lab, and do not use fetal cells in their production. https://factcheckni.org/articles/covid-19-vaccinesand-aborted-fetuses/
No, you will just need to delay your second COVID-19 vaccine dose to 90 days post monoclonal antibody treatment.
Receiving certain vaccines, primarily the seasonal influenza vaccine, may increase the risk of Guillain-Barre syndrome. The Advisory Committee on Immunization Practices (ACIP) lists history of GuillainBarre syndrome as a precaution to consider when receiving vaccines, but not a contraindication. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html There is currently limited data available about the risk of Guillain-Barre with COVID-19 vaccines. The [...]